Insulin degludec/liraglutide (IDegLira)

insulin degludec/liraglutide · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insulin degludec/liraglutide (IDegLira), covering 2017-01-20 to 2017-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus [Phase 3]

See pricing